CGIX

Cancer Genetics to Report First Quarter 2014 Results on Thursday, May 15, 2014

[GlobeNewswire] – RUTHERFORD, N.J. — Cancer Genetics, Inc. (CGI or the Company), an emerging leader in DNA-based diagnostics, announced today that it will report its financial results for the first … moreView todays social media effects on CGIXView the latest stocks trending across Twitter. Click to view dashboardSee who Cancer is hiring next, click here to view […]

Cancer Genetics Launches Genomic Tests for Follicular Lymphoma and Mantle Cell Lymphoma – Further Extends Unique Position in Targeted Testing of Hematologic Cancers

[GlobeNewswire] – RUTHERFORD, N.J. — Cancer Genetics, Inc. (CGI or the Company), an emerging leader in DNA-based diagnostics, today announced it has received CLIA and New York state approvals for … moreView todays social media effects on CGIXView the latest stocks trending across Twitter. Click to view dashboardSee who Cancer is hiring next, click here to view […]

CANCER GENETICS, INC Financials

moreView todays social media effects on CGIXView the latest stocks trending across Twitter. Click to view dashboardSee who Cancer is hiring next, click here to view […]

Cancer Genetics Announces Launch of CALR Mutation Analysis Test to Assist in Diagnosis of Acute Leukemias & Myeloproliferative Neoplasms

[GlobeNewswire] – RUTHERFORD, N.J. — Cancer Genetics, Inc. (CGI or the Company), an emerging leader in DNA-based cancer diagnostics, has launched a genetic diagnostic test for detecting mutations … moreView todays social media effects on CGIXView the latest stocks trending across Twitter. Click to view dashboardSee who Cancer is hiring next, click here to view […]

Cancer Genetics’ CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Panna Sharma Thank you, Michael. Hello and good afternoon everyone. Thank you for joining us today for our fourth quarter and 2013 year-end conference call. In recent quarters, we’ve had an opportunity … moreView todays social media effects on CGIXView the latest stocks trending across Twitter. Click to view dashboardSee who Cancer is hiring next, click […]

8:02 am Cancer Genetics announces compelling diagnostic sensitivity (99%) and accuracy (93%) for its patent-protected genomic kidney cancer test

moreView todays social media effects on CGIXView the latest stocks trending across Twitter. Click to view dashboardSee who Cancer is hiring next, click here to view […]